Related Experiment Video
Updated: Nov 24, 2025
04:49
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
Published on: July 5, 2024
1.4K
Pharmacologic Treatments for PCOS Patients
Samantha Kodama1, Saioa Torrealday2
1MedStar Washington Hospital Center, Washington, District of Columbia.
Clinical Obstetrics and Gynecology
|December 21, 2020
Summary
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women. This review details pharmacologic treatments for PCOS symptoms like infertility and metabolic issues when lifestyle changes are insufficient.
Area of Science:
- Reproductive Endocrinology
- Women's Health
- Metabolic Disorders
Background:
- Polycystic ovarian syndrome (PCOS) is the most prevalent endocrinopathy affecting reproductive-aged women.
- PCOS presents with diverse clinical manifestations including anovulatory infertility, menstrual irregularities, androgen excess symptoms, metabolic disturbances, and mental health concerns.
- Untreated PCOS can lead to severe long-term complications such as endometrial hyperplasia, type 2 diabetes mellitus, and dyslipidemia.
Purpose of the Study:
- To review the pharmacologic treatment options for managing the multifaceted sequelae of polycystic ovarian syndrome.
- To provide clinicians with an overview of available medications to address common PCOS-related issues.
Main Methods:
- Literature review of pharmacologic therapies for PCOS.
- Synthesis of current treatment guidelines and clinical evidence.
Main Results:
- Lifestyle modifications are the first line of treatment for PCOS.
- Pharmacologic interventions are crucial when lifestyle changes fail to adequately manage PCOS symptoms.
- Various medications target specific PCOS manifestations, including ovulation induction, androgen reduction, and metabolic regulation.
Conclusions:
- Comprehensive management of PCOS requires addressing all its components.
- Pharmacologic therapy is essential for effectively treating the diverse clinical presentations and long-term risks associated with PCOS.
- Timely and appropriate pharmacologic treatment can mitigate the sequelae of polycystic ovarian syndrome.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
322
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
322
01:21Drugs for Treatment of Constipation-Predominant IBS
513
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
513
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
465
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
465
01:28Drug Therapy
156
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
156
01:15Diabetes: Management and Pharmacotherapy
723
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
723
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
111
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
111